Stratos Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Stratos Wealth Advisors, LLC

$2.13 Billion
Q3 2024

A detailed history of Stratos Wealth Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 8,648 shares of REGN stock, worth $6.07 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

8,648

Previous 8,678 0.35%

Holding current value

$6.07 Million

Previous $9.12 Million 0.32%

% of portfolio

0.43%

Previous 0.46%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$1024.09 - $1201.76 $30,722 - $36,052	-30 Reduced 0.35%	8,648 $9.09 Million
Q2 2024 Jul 24, 2024	BUY	$883.2 - $1071.19 $188,121 - $228,163	213 Added 2.52%	8,678 $9.12 Million
Q1 2024 Apr 16, 2024	BUY	$902.69 - $993.35 $140,819 - $154,962	156 Added 1.88%	8,465 $8.15 Million
Q3 2023 Oct 24, 2023	BUY	$692.45 - $844.37 $184,191 - $224,602	266 Added 3.31%	8,309 $6.84 Million
Q2 2023 Jul 18, 2023	BUY	$700.03 - $830.35 $126,005 - $149,463	180 Added 2.29%	8,043 $5.78 Million
Q1 2023 Apr 27, 2023	BUY	$680.49 - $826.97 $544,392 - $661,576	800 Added 11.33%	7,863 $6.46 Million
Q4 2022 Jan 19, 2023	BUY	$705.89 - $766.39 $3.37 Million - $3.66 Million	4,781 Added 209.51%	7,063 $0
Q3 2022 Oct 24, 2022	BUY	$573.97 - $724.32 $184,818 - $233,231	322 Added 16.43%	2,282 $1.57 Million
Q2 2022 Jul 22, 2022	BUY	$548.35 - $738.84 $397,553 - $535,659	725 Added 58.7%	1,960 $1.16 Million
Q1 2022 Apr 26, 2022	SELL	$595.12 - $698.43 $451,696 - $530,108	-759 Reduced 38.06%	1,235 $863,000
Q4 2021 Jan 14, 2022	BUY	$543.48 - $670.97 $176,631 - $218,065	325 Added 19.47%	1,994 $1.26 Million
Q3 2021 Oct 19, 2021	BUY	$574.03 - $680.96 $958,056 - $1.14 Million	1,669 New	1,669 $1.01 Million
Q2 2021 Jul 19, 2021	SELL	$472.8 - $558.54 $272,332 - $321,719	-576 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$446.73 - $548.2 $257,316 - $315,763	576 New	576 $273,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.

Account

Stratos Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History